May 2, 2019
Sanofi’s dengue vaccine approved in USA
Sanofi’s dengue vaccien Dengvaxia was approved in the USA, the company said in a press release Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
May 2, 2019
Lilly presents new Emgality data
Eli Lilly will present 19 scientific abstracts for headache preventive drug Emgality (galcanezumab-gnlm) and lasmiditan at the 71st Annual Meeting of the American Academy of Neurology (AAN) taking place in Philadelphia from May 4-10, 2019.
May 2, 2019
Smoothened Homolog (Protein Gx or SMO) Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smoothened Homolog (Protein Gx or SMO) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
May 2, 2019
Hypoglycemia Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
May 2, 2019
Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
May 2, 2019
Chronic Kidney Disease: Worldwide Markets & Technologies 2017-2023 with Key Insights into Research on CKD Comorbidities, as Well as Treatment Methods & Diagnostics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Chronic Kidney Disease: Global Markets and Technologies Through 2023” report has been added to ResearchAndMarkets.com’s offering. The focus…
May 2, 2019
Post-Operative Pain – Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
May 2, 2019
Transgene, AstraZeneca in exclusive license option deal for new oncolytic immunotherapies
Transgeen in agreement with AstraZeneca to co-developfive armed oncolytic vaccinia virus candidates. Innovative oncolyticviruses resulting from this collaboration will use Transgene’sproprietary next generation viral platform Invir.IO
May 2, 2019
Veeva, Cvent integrate Best-in-Class Events Management Capabilities
Industry leaders partner to help life sciences companies compliantlymanage global events
May 1, 2019
1-Day Seminar: Drafting & Negotiating Clinical Trial Agreements
Clinical trial agreements are one of the most important agreements inthe pharma industry as no research can start without the right agreementin place between sponsor and host organisation.